Medicover AB (publ) (MCOV-B.ST) Stock Analysis & Winston Score
Medicover is a healthcare company that runs hospitals, clinics, and diagnostic labs across Europe and India. It serves everyday patients who need doctor visits, medical tests, blood work, and hospital care. The company operates under the Medicover brand and is one of the larger private healthcare networks in Central and Eastern Europe. Medicover makes money by charging patients and insurance companies for medical services and lab tests. It operates in over 15 countries, with a strong presence in Poland, Germany, Romania, and India, and generates roughly €1.8 billion in annual revenue. Its main competitive advantage is its dense network of clinics and labs, which is hard and expensive for new competitors to replicate. The key growth driver is rising demand for private healthcare in emerging European markets, where public health systems are often overcrowded. The main risk is that thin operating margins leave little room for error if costs rise or patient volumes slow.
Winston Score: 50/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Weak (7/30)
- Growth: Exceptional (18/20)
- Cash Flow: Strong (8/10)
- Stability: Mixed (4/10)
- Valuation: Weak (2/10)
- Ownership: Good (10/15)
Key Facts
Price: $214.00
Market Cap: $32.3B
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: Stockholm Stock Exchange


